Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioDiem Ltd.
DescriptionSynthetic peptide
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat retinitis pigmentosa (RP)
Regulatory Designation U.S. - Orphan Drug (Treat retinitis pigmentosa (RP))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today